Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


AUT UNI Logo blkScientists to tackle traumatic brain injury

AUT UNI Logo blkScientists to tackle traumatic brain injury

AUT University researchers have joined an international team of 38 scientific institutes and 60 European hospitals aiming to create better and more targeted treatments for Traumatic Brain Injury (TBI).

The 30 million euro (NZ$50 million) project will collect and analyse data in more than 5000 patients across Europe and more than 1300 participants from New Zealand, and will run for six years from October 2013.

The Collaborative European NeuroTrauma Effectiveness Research (CENTER-TBI) project is part of a global collaboration established by the European Commission, the National Institutes of Health in the US and the Canadian Institute of Health Research. Seldom has such a large collaboration been implemented by funding agencies.

Professor Valery Feigin, Director of the National Institute for Stroke and Applied Neurosciences (NISAN) at AUT University, says, “Recent research that we carried out in New Zealand shows TBI rates are six times higher than previously thought, and urgent actions are required to stop this silent epidemic and improve outcomes. We look forward to using our findings to further global understanding of TBI and help develop better treatment.”

Professor Feigin and Dr Alice Theadom, Senior Research Fellow at NISAN, will use data from their recently published epidemiological paper Incidence of TBI in NZ: A Population Based Study to examine rates of hospital attendance for TBI in rural and urban areas.

They will also look at moderate and severe cases of TBI in New Zealand to compare outcomes among people who had a CT scan and those who didn’t.

The international collaboration will use new approaches to prognostic modelling developed by Professor Nikola Kasabov, Director of the Knowledge Engineering & Discovery Research Institute at AUT University, to create personalised strategies for improving TBI outcomes.

TBI is called the “silent epidemic” because early and late effects are often disabling, even years after injury. In survivors, disability results in high socio-economic costs. In low and middle income countries incidences of TBI are increasing at an alarming rate. Despite many advances in medical care, outcomes for patients with TBI have changed little over the past 20 years and doctors do not yet fully understand the disease.

Treating TBI caused by accidents, falls or violence is challenging because there are no universally accepted evidence-based guidelines and treatment strategies vary between countries.

CENTER-TBI is funded by the European Union’s Seventh Framework Programme for Research and Development, and coordinated by Professor Andrew Maas from Antwerp University Hospital (Belgium) and Professor David Menon from the University of Cambridge (UK). The project’s launch in Antwerp, Brussels on 11 and 12 October 2013 was attended by 80 experts from Europe, China, America and Australia.

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Auckland Outage: Power Mostly Restored Overnight

Vector wishes to advise that all but 324 customers have been restored overnight. These customers are spread throughout the network in small pockets. The main St Johns feeder was restored around midnight allowing most of the customers in all affected areas to have power this morning. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
More RSS  RSS
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news